文献速递关节外科创伤骨科

氨甲环酸在有静脉血栓栓塞史关节置换患者中安全:一项考虑术者选择偏倚的分析

Tranexamic Acid Is Safe in Arthroplasty Patients Who Have a History of Venous Thromboembolism: An Analysis Accounting for Surgeon Selection Bias.
PubMed 文献 · J Arthroplasty · 2024-11-16

该回顾性数据库研究纳入2015至2021年有深静脉血栓或肺栓塞史并接受择期关节置换的患者,按术者使用氨甲环酸(TXA)的频率分为低频组(0-30%病例)和高频组(90-100%病例),采用工具变量分析。结果显示高频TXA组出血并发症风险较低(工具变量OR 0.94,95%CI 0.89-0.98,P=0.005),输血风险更低(OR 0.60,95%CI 0.54-0.66,P<0.001),而深静脉血栓、肺栓塞、卒中和心肌梗死无显著差异(P>0.05)。作者认为在考虑术者选择后,TXA与早期出血并发症减少相关且未增加血栓栓塞风险,建议术者可考虑在高危关节置换患者中使用TXA。

要点

  • 有静脉血栓栓塞史的择期关节置换患者中,高频使用TXA的术者其患者出血并发症风险较低(工具变量OR 0.94,95%CI 0.89-0.98,P=0.005)。
  • 高频TXA组输血风险显著低于低频组(工具变量OR 0.60,95%CI 0.54-0.66,P<0.001)。
  • 两组术后深静脉血栓、肺栓塞、卒中和心肌梗死无显著差异(P>0.05)。

核心结论

  • 在考虑术者选择后,TXA使用与早期术后出血并发症显著减少相关,未观察到血栓栓塞风险增加。
  • 鉴于良好的安全性,作者建议术者可考虑在有静脉血栓栓塞史的高危关节置换患者中使用TXA。

研究设计与样本

  • 回顾性查询2015至2021年医疗数据库,纳入有深静脉血栓或肺栓塞史并接受择期关节置换的患者。
  • 按术者TXA使用频率分为低频组(0-30%病例使用TXA)和高频组(90-100%病例使用TXA),基于术者而非患者TXA暴露进行评估。
  • 比较两组人口学、合并症及90天术后并发症发生率,并采用多变量和以术者为工具变量的工具变量分析控制混杂因素。

主要发现

  • 共识别70,759例高危择期关节置换患者,其中7,190例(10.2%)由低频TXA组术者完成,9,478例(13.4%)由高频TXA组术者完成。
  • 工具变量分析显示,高频TXA组术者治疗的患者聚合出血并发症风险较低(工具变量OR 0.94,95%CI 0.89-0.98,P=0.005),包括输血(工具变量OR 0.60,95%CI 0.54-0.66,P<0.001)。
  • 两组术后深静脉血栓、肺栓塞、卒中和心肌梗死无显著差异(P>0.05)。

关键数值与推荐

  • 高频TXA组术者治疗的患者聚合出血并发症工具变量OR 0.94(95%CI 0.89-0.98,P=0.005),低于低频TXA组术者治疗的患者。
  • 高频TXA组术者治疗的患者输血工具变量OR 0.60(95%CI 0.54-0.66,P<0.001),低于低频TXA组术者治疗的患者。
  • 两组术后深静脉血栓、肺栓塞、卒中和心肌梗死无显著差异(P>0.05)。

临床怎么用

  • 作者建议术者可考虑在有静脉血栓栓塞史的高危关节置换患者中使用TXA。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retrospective data supporting the use of tranexamic acid (TXA) among high-risk total joint arthroplasty (TJA) patients are limited by surgeon selection bias. This study sought to evaluate the thromboembolic risk associated with TXA administration among elective arthroplasty patients who have history of venous thromboembolism while accounting for surgeon selection. METHODS: A healthcare database was retrospectively queried from 2015 to 2021 to identify all patients who had a history of deep vein thrombosis or pulmonary embolism who underwent elective TJA. Patients were categorized into two cohorts: (1) patients treated by a surgeon who used TXA in 0 to 30% of cases; and (2) patients treated by a surgeon who used TXA in 90 to 100% of cases. Patients were assessed based on the surgeon who treated them rather than their exposure to TXA. Demographics, comorbidities, and the incidence of 90-day postoperative complications were compared between the two groups. Multivariable and instrumental variable analysis using surgeon as an instrument were conducted to account for confounding factors. RESULTS: In total, 70,759 high-risk elective TJA patients were identified, of which 7,190 (10.2%) were performed by surgeons in the infrequent-TXA cohort and 9,478 (13.4%) were performed by surgeons in the frequent-TXA cohort. On instrumental variable analysis, patients treated by surgeons in the frequent-TXA cohort had a lower risk of aggregate bleeding complications (instrumental variable odds ratio 0.94, 95% confidence interval: 0.89 to 0.98, P = 0.005), including transfusion (instrumental variable odds ratio 0.60, 95% confidence interval: 0.54 to 0.66, P < 0.001). However, no significant differences were observed in postoperative deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction between the two cohorts (P > 0.05). CONCLUSIONS: After accounting for surgeon selection, TXA administration was associated with a significant reduction in early postoperative bleeding complications with no observed increase in thromboembolic risk. Given the favorable safety profile, surgeons should consider TXA among high-risk arthroplasty patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Palmer RC, Telang SS, Wier J, et al. Tranexamic Acid Is Safe in Arthroplasty Patients Who Have a History of Venous Thromboembolism: An Analysis Accounting for Surgeon Selection Bias. J Arthroplasty. 2024. PMID: 39551413. doi:10.1016/j.arth.2024.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。